A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 Following Single Intravenous Dose Administration in Healthy Male Subjects

Trial Profile

A Study to Investigate the Metabolism and Excretion of [14C]-TRV130 Following Single Intravenous Dose Administration in Healthy Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Nov 2015

At a glance

  • Drugs Oliceridine (Primary)
  • Indications Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors Trevena
  • Most Recent Events

    • 17 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 16 Jul 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Jul 2014 to 1 Jul 2015.
    • 20 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top